期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 56, 期 14, 页码 5637-5658出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm301424d
关键词
-
资金
- MIUR
- Ministero degli Affari Esteri, Direzione Generale per la Promozione del Sistema Paese
- Dote Ricerca: FSE, Regione Lombardia
Rhodesain, a cathepsin L-like cysteine protease of T. brucei rhodesiense, is considered a potential target for the treatment of human African trypanosomiasis. Recent findings have confirmed that rhodesain, a lysosomal protease, is essential for parasite survival. Rhodesain is required by T. brucei to cross the blood-brain barrier, degrade host immunoglobulins, and turn over variant surface coat glycoproteins of T. brucei, which impair effective host immune responses. In this Perspective, we discuss the main classes of rhodesain inhibitors, including peptidic, peptidomimetic, and nonpeptidic structures, emphasizing those that have exhibited an optimal match between enzymatic affinity and trypanocidal profile and those for which predinical investigations are currently in progress.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据